Ampliphi Biosciences Corp (NYSEAMERICAN:APHB - Get Free Report)'s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.00 and traded as low as $1.65. Ampliphi Biosciences shares last traded at $1.65, with a volume of 6,450 shares trading hands.
Ampliphi Biosciences Stock Performance
The stock has a 50-day moving average of $1.98.
About Ampliphi Biosciences
(
Get Free Report)
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
Before you consider Ampliphi Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.
While Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
